Fortress Biotech

FBIO · NASDAQ

$1.94+$0.07 (+3.74%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $1.87

Latest news

Press releaseSep 8, 4:05 PM ETGlobe Newswire
Journey Medical Corporation to Participate in September 2026 Investor Conferences
Press releaseAug 13, 4:05 PM ETGlobe Newswire
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Press releaseAug 12, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Press releaseAug 7, 12:45 PM ETPRNewswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Fortress Biotech, Inc. (NASDAQ: FBIO)
Press releaseAug 5, 8:30 AM ETGlobe Newswire
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
NewsJul 27, 8:03 AM ET
Fortress Biotech’s Urica Therapeutics Says Crystalys Closes Oversubscribed $130M Series B Financing To Support Late-Stage Global Clinical Development And Commercialization Preparation For Dotinurad
Press releaseJul 27, 8:00 AM ETGlobe Newswire
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
NewsMay 14, 5:29 PM ET
Fortress Biotech Q1 EPS $2.82 Beats $(0.22) Estimate, Sales $16.038M Miss $16.338M Estimate
Press releaseMay 14, 4:10 PM ETGlobe Newswire
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Press releaseMay 13, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Press releaseMay 6, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
Press releaseMar 31, 4:05 PM ETGlobe Newswire
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
Press releaseMar 30, 4:05 PM ETGlobe Newswire
Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
Press releaseMar 25, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Press releaseMar 18, 8:30 AM ETGlobe Newswire
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
Press releaseFeb 23, 9:24 AM ETGlobe Newswire
UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
Press releaseFeb 23, 8:30 AM ETGlobe Newswire
Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
NewsNov 14, 8:43 AM ET
Fortress Biotech Q3 EPS $0.11 Beats $(0.42) Estimate, Sales $17.631M Miss $21.018M Estimate
Press releaseNov 14, 8:30 AM ETGlobe Newswire
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseNov 12, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseNov 5, 8:30 AM ETGlobe Newswire
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
Press releaseOct 28, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Press releaseOct 23, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Press releaseOct 18, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Press releaseOct 13, 1:50 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Press releaseOct 8, 5:45 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
Press releaseOct 1, 3:45 PM ETGlobe Newswire
Fortress Biotech Investigated by the Portnoy Law Firm
Press releaseOct 1, 11:58 AM ETGlobe Newswire
INVESTOR ALERT: Investigation of Fortress Biotech, Inc. (FBIO) Announced by Holzer & Holzer, LLC
NewsOct 1, 8:16 AM ETAvi Kapoor
Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
NewsSep 5, 5:20 AM ETAvi Kapoor
Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
NewsSep 4, 5:13 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsAug 29, 5:06 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
Press releaseAug 12, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseAug 5, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
Press releaseJun 9, 8:30 AM ETGlobe Newswire
Journey Medical Corporation Announces Emrosi™ Featured on "The Balancing Act" Airing on Lifetime TV
Press releaseMay 15, 4:05 PM ETGlobe Newswire
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseMay 14, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Press releaseMay 13, 4:15 PM ETGlobe Newswire
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates
Press releaseMay 7, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
Press releaseMar 31, 4:05 PM ETGlobe Newswire
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights
Press releaseMar 28, 8:30 AM ETGlobe Newswire
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
Press releaseMar 26, 4:01 PM ETGlobe Newswire
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
Press releaseMar 19, 4:01 PM ETGlobe Newswire
Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025
Press releaseMar 12, 8:30 AM ETGlobe Newswire
Journey Medical Corporation to Participate in the 37th Annual ROTH Conference
Press releaseMar 9, 10:06 PM ETPRNewswire
Sun Pharma to Acquire Checkpoint Therapeutics
Press releaseNov 14, 4:10 PM ETGlobe Newswire
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
NewsSep 20, 12:15 PM ETHenry Khederian
Why Fortress Biotech (FBIO) Stock Is Getting Hammered
NewsJul 12, 8:42 AM ETAvi Kapoor
Around $10M Bet On This Tech & Telecom Stock? Check Out These 3 Stocks Insiders Are Buying
NewsJul 11, 7:29 AM ETAvi Kapoor
Insiders Buying Fortress Biotech And 2 Other Stocks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Journey Medical Corporation to Participate in September 2026 Investor Conferences

Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Fortress Biotech, Inc. (NASDAQ: FBIO)

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Fortress Biotech’s Urica Therapeutics Says Crystalys Closes Oversubscribed $130M Series B Financing To Support Late-Stage Global Clinical Development And Commercialization Preparation For Dotinurad

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

Fortress Biotech Q1 EPS $2.82 Beats $(0.22) Estimate, Sales $16.038M Miss $16.338M Estimate

Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights

Fortress Biotech's Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million

Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

UPDATE: Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

Fortress Biotech's Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million

Fortress Biotech Q3 EPS $0.11 Beats $(0.42) Estimate, Sales $17.631M Miss $21.018M Estimate

Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO

Fortress Biotech Investigated by the Portnoy Law Firm

INVESTOR ALERT: Investigation of Fortress Biotech, Inc. (FBIO) Announced by Holzer & Holzer, LLC

Cal-Maine Foods Posts Downbeat Earnings, Joins Enanta Pharmaceuticals, AAR And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025

Journey Medical Corporation Announces Emrosi™ Featured on "The Balancing Act" Airing on Lifetime TV

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025

Journey Medical Corporation to Participate in the 37th Annual ROTH Conference

Sun Pharma to Acquire Checkpoint Therapeutics

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Why Fortress Biotech (FBIO) Stock Is Getting Hammered

Around $10M Bet On This Tech & Telecom Stock? Check Out These 3 Stocks Insiders Are Buying

Insiders Buying Fortress Biotech And 2 Other Stocks